NAD+, NMN and Cellular Energy: What the Research Actually Shows
Few areas of supplement science attract as much attention, or as much overreach, as cellular energy and healthy ageing. NAD+ precursors, mitochondria-targeted antioxidants and sirtuin-activating compounds now sit at the centre of a large and growing research literature. They are also surrounded by marketing that runs well ahead of what the studies say.
This guide takes the opposite approach. It walks through the biology that the compounds act on, summarises what the research is genuinely investigating, and is honest about where the evidence is still preliminary. If you are an evidence-minded reader trying to separate signal from hype, the aim here is to give you the vocabulary and the caveats, not a promise. For New Zealand readers researching NMN or longevity supplements, this guide covers the evidence without the overreach.
The molecule at the centre: NAD+
Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme present in every living cell. It sits at the heart of the reactions that convert food into usable energy, shuttling electrons through the metabolic pathways that ultimately produce ATP, the cell's energy currency. Beyond metabolism, NAD+ is a required substrate for two important families of enzymes: the sirtuins, which are involved in DNA and metabolic regulation, and the PARPs, which participate in DNA repair.
Research has consistently reported that tissue NAD+ levels decline with age in a range of organisms and human tissues. This observation is one of the most-cited findings in the field, and it is the reason so much attention has turned to whether replenishing NAD+ is meaningful. It is worth being precise about what this means: an age-associated decline in a measured biomarker is a correlation observed in research. It is not, by itself, evidence that raising the marker changes how a person ages.
The salvage pathway: how cells top up NAD+
Cells don't usually build NAD+ from scratch. Instead, most of it is recycled through what biochemists call the salvage pathway. In this loop, NAD+ that has been consumed by sirtuins and other enzymes is broken down to nicotinamide, and a series of enzymatic steps rebuilds it back into fresh NAD+.
Two intermediates in and around this pathway are the ones you see on supplement labels: nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are precursors, molecules the body can convert onward toward NAD+. The logic studied in the literature is straightforward: supplying more precursor may support the salvage pathway's capacity to maintain NAD+ levels. Human trials of NMN and NR have generally reported that oral dosing can raise blood NAD+ markers, and these studies have broadly described the compounds as well tolerated over the periods tested. What remains an active research question is whether those biomarker shifts translate into the functional outcomes people care about.
This is where honest framing matters. NAD+ precursors are studied for their effects on metabolism, exercise physiology and markers of cellular ageing. The research is real and ongoing. But the human outcome data are still early, and no responsible reading of it supports language about reversing ageing or guaranteeing an energy result.
If NMN is the precursor you want to explore, Super NMN 500mg is a straightforward, standardised dose. For a delivery-focused option, Quicksilver NAD+ Gold uses a liposomal format designed to protect the molecule through digestion, a delivery question we return to below.
Mitochondria: where the energy actually happens
If NAD+ is the currency, mitochondria are the mints. These are the compartments inside cells where the electron transport chain assembles ATP. They are also, unavoidably, where a large share of the body's reactive oxygen species (ROS) are produced as a by-product of energy generation.
A modest level of ROS is normal cellular signalling. The research interest is in oxidative stress, the state where ROS production outpaces the cell's antioxidant defences. Mitochondrial function and oxidative balance both shift with age in the research literature, which is why the compounds below are studied specifically for their effects at the mitochondrial level rather than as general antioxidants.
Getting antioxidants to the mitochondria: MitoQ and CoQ10
Coenzyme Q10 (CoQ10) is a component of the electron transport chain and a well-studied antioxidant. A recurring problem in the research, however, is that ordinary CoQ10 does not readily concentrate inside mitochondria, where much of the relevant chemistry occurs.
MitoQ, a New Zealand-developed compound, was designed to address exactly this. It attaches a CoQ10-derived antioxidant to a positively charged molecule that is drawn across the mitochondrial membrane, so the antioxidant accumulates where ROS are generated. This mitochondria-targeting mechanism is what the research literature has examined across a range of models and human trials, studying its effects on markers of oxidative stress and vascular function. MitoQ Pure is the standalone form of this compound.
Some formulations pair the mitochondria-targeting approach with other studied actives. MitoQ + Curcumin combines it with curcumin, a polyphenol researched for its own antioxidant and inflammatory-pathway activity, so the two are investigated together in a single formula.
PQQ: studied for mitochondrial biogenesis
Pyrroloquinoline quinone (PQQ) is a smaller player in the public conversation but an interesting one in the research. Beyond acting as an antioxidant, PQQ has been studied for its association with mitochondrial biogenesis, the cellular process of producing new mitochondria, in laboratory and animal models. Human data are more limited, and the appropriate framing is that PQQ is an area of active investigation rather than a settled ingredient. You will often find it alongside NAD+ precursors and CoQ10 in comprehensive formulas rather than on its own.
Sirtuins and resveratrol: the polyphenol chapter
The sirtuin story is where NAD+ connects to the most famous compound in longevity research: resveratrol.
Sirtuins are a family of enzymes that depend on NAD+ to function. In research, they have been implicated in regulating metabolism, mitochondrial activity and cellular stress responses. Because their activity is tied to NAD+ availability, sirtuins are a mechanistic link between the "precursor" chapter above and the "polyphenol" chapter here.
Resveratrol, a polyphenol found in grape skins, red wine and Japanese knotweed, first drew attention as a compound reported to interact with sirtuin pathways in laboratory studies. The early cell and animal work generated enormous excitement, some of which has since been tempered by more cautious human research. Resveratrol has notably poor oral bioavailability, which complicates interpretation of trials that use unenhanced forms. The current, honest position is that resveratrol is studied for its interactions with sirtuin and metabolic pathways, and it remains a genuinely active research area, not a proven longevity intervention. Metagenics Resveratrol Healthy Ageing is a standardised resveratrol formulation for readers who want to explore this pathway.
Delivery matters: the liposomal question
Several of the compounds in this space (NAD+ itself, resveratrol, glutathione) share a practical problem: they are fragile or poorly absorbed when taken as ordinary capsules. The digestive tract degrades some of them; others simply don't cross into the bloodstream efficiently.
This is the reasoning behind liposomal delivery. A liposome is a microscopic sphere with a phospholipid shell, the same class of molecule your own cell membranes are built from. Encapsulating an active inside a liposome is studied as a way to shield it through digestion and improve how much reaches circulation. It is why you see so many "liposomal" labels in this category, and why delivery format, not just the active ingredient, is worth paying attention to when you read the research.
For readers who prefer a single comprehensive formula rather than assembling individual actives, Quicksilver The One brings together a mitochondrial-support blend in one liposomal delivery system. The blend includes a NAD+ precursor, ubiquinol (a form of CoQ10), PQQ and resveratrol, so the multiple pathways discussed here are combined in a single liposomal formula.
How to read this evidence honestly
If there is one habit worth carrying away from this guide, it is the discipline of distinguishing mechanism from outcome.
- Mechanism is what a compound does in a cell or a test tube: NMN feeds the salvage pathway, MitoQ concentrates in mitochondria, resveratrol interacts with sirtuins. The mechanistic story for these compounds is genuinely interesting and well-documented.
- Outcome is what happens to a person over time. This is the harder, slower evidence, and across most of this category it is still developing. Age-associated declines in NAD+ and mitochondrial function are well-established observations; whether supplementing changes the trajectory of ageing in humans is an open question that serious researchers are still working on.
A few practical principles follow from that. Look for standardised doses and transparent labelling. Take delivery format seriously, because a well-absorbed modest dose can be more meaningful than a large dose that never reaches your cells. And treat any product that promises to reverse ageing or guarantee an energy result with scepticism, because the science it claims to rest on does not make those promises.
It also helps to read individual trials in context rather than in isolation. A single positive study showing that oral NMN raised a blood NAD+ marker is a useful data point, but it sits inside a literature that is still small, often short in duration, and varied in the populations and doses studied. Researchers themselves tend to frame these results as early and hypothesis-generating, calling for larger and longer trials before drawing conclusions about human ageing. When you see a compound described here as studied for a pathway, that phrasing is deliberate: it marks the difference between a mechanism that is well-characterised in cells and an outcome that has been demonstrated, reproducibly, in people over time. Holding that distinction is the single most protective habit an evidence-minded reader can bring to this category.
Where to start
There is no single "right" entry point, because these compounds map onto different pathways. Broadly, NAD+ precursors like NMN and NAD+ Gold address the salvage pathway; MitoQ and CoQ10-based formulas target mitochondrial oxidative balance; resveratrol sits in the sirtuin-polyphenol chapter; and comprehensive blends like The One combine several pathways at once. You can explore the full range in the Energy & Longevity collection.
Cellular energy and healthy ageing are among the most active frontiers in supplement research. The compounds are real, the mechanisms are well-characterised, and the human outcome data are still being written. The most useful thing an evidence-minded reader can do is hold both of those truths at once: genuine scientific interest, and genuine humility about what is not yet proven.
References
- Massudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 2012; 7(7):e42357. DOI: 10.1371/journal.pone.0042357
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (human NMN trial). Science, 2021; 372(6547):1224-1229. DOI: 10.1126/science.abe9985
- Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ (triphenylphosphonium-driven accumulation across the mitochondrial membrane). Annals of the New York Academy of Sciences, 2010; 1201:96-103. DOI: 10.1111/j.1749-6632.2010.05627.x
- Pharmacokinetic literature on resveratrol oral bioavailability and quercetin co-administration.
This article describes findings from published research for general educational purposes. It is not medical advice, and nothing here is intended to diagnose, treat, cure, or prevent any disease. If you take prescription medication or have a health condition, consult a qualified healthcare professional before adding a supplement.